Physician profile
James R Malcolm
NPI 1740283431
$294,911.27
in general payments reported to CMS, 2019-2025
44 companies · $3,572 in 2025
The $3,572 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $78K · 2021: $53K · 2022: $45K · 2023: $21K · 2024: $30K · 2025: $3,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Royalty Or License: $10K · Food and Beverage: $7,221 · Travel and Lodging: $6,091 · Entertainment: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,989.00 |
| Royalty Or License | $10,340.72 |
| Food and Beverage | $7,221.45 |
| Travel and Lodging | $6,091.33 |
| Entertainment | $169.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $122,608.58 | 2019-2025 | Simplify Cervical Artificial Disc, Excelsiusgps Robotic Navigation System, Revere Addition |
| 4web, INC. | $75,385.29 | 2019-2025 | Spine Truss System |
| Stryker Corporation | $24,549.88 | 2019-2024 | Everest Spinal System, Xia 3, Bio4 |
| Mirus, LLC | $18,000.00 | 2020 | |
| Nuvasive, INC. | $13,527.32 | 2019-2023 | Simplify Cervical Artificial Disc, Xlif |
| Surgalign Spine Technologies, INC. | $10,359.97 | 2019-2022 | |
| Spineart Sa | $9,277.00 | 2023-2025 | Cure Acp - Anterior Cervical Plate |
| Alphatec Spine, INC | $7,310.96 | 2019-2025 | Invictus Open, Other - Miscellaneous, Identiti |
| Cerapedics INC. | $5,570.44 | 2020-2024 | I-Factor Peptide Enhanced Bone Graft |
| Carlsmed, INC. | $2,104.19 | 2024 | Aprevo |
| Ossdsign USA Incorporated | $523.50 | 2024-2025 | Ossdsign Catalyst |
| Medacta USA, INC. | $483.31 | 2019-2024 | |
| Neo Spine USA, INC. | $390.41 | 2022 | |
| Baxter Healthcare | $379.13 | 2020-2022 | |
| Sanara Medtech INC. | $306.79 | 2021-2022 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $302.60 | 2025 | |
| Centinel Spine, LLC | $288.21 | 2019-2024 | Prodisc L |
| Zimmer Biomet Holdings, INC. | $276.93 | 2019-2021 | |
| Nevro Corp. | $250.83 | 2020-2023 | Senza |
| Radius Health, INC. | $234.21 | 2021-2024 | Tymlos |
| Camber Spine Technologies LLC | $228.47 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $228.41 | 2021-2022 | |
| Spine Wave, INC. | $222.18 | 2019 | |
| Seaspine Orthopedics Corporation | $213.47 | 2020-2021 | |
| Medical Device Business Services, INC. | $187.83 | 2021-2023 | Teligen |
| Ulrich Medical USA, INC. | $169.56 | 2023 | |
| Si-Bone, INC. | $167.25 | 2019-2023 | |
| Mml US, INC. | $160.69 | 2021 | |
| Xtant Medical INC | $139.03 | 2025 | |
| Nanovis LLC | $137.69 | 2023 | |
| Abbott Laboratories | $136.53 | 2021 | |
| Depuy Synthes Sales INC. | $126.48 | 2019-2024 | Matrixneuro |
| Smith+Nephew, INC. | $121.27 | 2019-2020 | |
| Medtronic, INC. | $118.12 | 2024 | Intellis Adaptivestim, Space-D System 5.5/6.0 Voyager Instrument Set |
| Aesculap Implant Systems, LLC | $100.94 | 2024 | Activl |
| Spineology INC. | $78.90 | 2020-2022 | |
| Axogen | $76.26 | 2020 | |
| Checkpoint Surgical, INC | $58.05 | 2020 | |
| Anika Therapeutics, INC. | $23.84 | 2023 | Atlas |
| Medicrea USA, Corp. | $21.36 | 2019 | |
| Melinta Therapeutics, LLC | $18.25 | 2019 | |
| Kuros Biosciences USA, INC | $18.15 | 2023 | |
| Boston Scientific Corporation | $14.69 | 2025 | Intracept |
| Pacira Therapeutics, INC. | $14.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$10,565,909.96 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Malcolm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.